B. Braun Precision Medicine Technology (Shanghai) Ltd. is a legal entity newly established by B. Braun in China. Through collaboration with CeGaT GmbH., an European leading genomics and transcriptomics center in Germany, the business scope of B. Braun Precision Medicine (BBPM) covers different type products in the fields of precision medicine, medical science and genomic technology in China. Based on top-notch NGS panel products platform, BBPM will provide a wide array of comprehensive and unique medical services including clinical genetic testing and counselling service to patients covering hereditary disease, tumor treatment, whole exon testing etc. as well as health management consulting service with personalized high-end oversea health service to consumers and genomic lab total-solutions directly to medical centers or doctor groups.

The establishment of B. Braun Precision Medicine Technology (Shanghai) Ltd. is a landmark for B. Braun to enter precision medicine and service market in China. The business starts at the right time because precision medicine market in China is experiencing a remarkably rapid growth. Precision medicine as one of the major projects has been included in China’s 13th Five-year Plan, expecting a continuous increase of investment and attentions into the field in next few years.

At the internal level of B. Braun China, System Partnership initiative, with the objective to provide comprehensive and systematic service to medical institutions, has been launched and is making great progresses in many provinces of the country. Cooperating with German partner, CeGaT GmbH, relying on efficient business platform of B. Braun, utilizing the company’s rich experience and resources accumulated in healthcare industry, insisting on principle of “Sharing Expertise”, B. Braun Precision Medicine will definitely create new highlights for B. Braun China by bringing innovation and high-quality services/products to China.